Ovintiv Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $9.5B+6.5% YoYTTM through 30 Jun 2026
Net Income $920M-18.2% YoYTTM through 30 Jun 2026
Free Cash Flow $2.3BTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 51.9% |
| EBITDA Margin | 32.6% |
| Operating Margin | 23.9% |
| Net Margin | 9.7% |
Returns
11.1%ROE
6.1%ROA
11.5%ROIC
Balance Sheet Health
Debt / Equity0.46x
Current Ratio0.54x
Net Debt$4.9B
Cash & Equivalents$700M
Quality Metrics
Altman Z-Score2.06
Piotroski F-Score6 / 9
FCF Margin23.8%
Rule of 4029.2
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $8.9B
Diluted EPS$3.58TTMFY2025: $4.78
Dividend
$0.60Per share, FY20263.10%Yield+5.1%5-yr growth
Capital Allocation
Capex Intensity23.0%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| USA Operations | $5.9B | -16.7% | View detailsFocusing on high-margin Permian Basin development with planned capital investment of $1.325 billion to $1.375 billion in 2026. |
| Canadian Operations | $2.8B | +47.7% | View detailsStrengthened by the NuVista acquisition closed in February 2026, adding 100 MBOE/d of production capacity. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.